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Abstract
Background: We previously showed that evaluation of anti-inflammatory activities of lactic acid bacteria in porcine
intestinal epithelial (PIE) cells is useful for selecting potentially immunobiotic strains.
Objective: The aims of the present study were: i) to select potentially immunomodulatory bifidobacteria that beneficially
modulate the Toll-like receptor (TLR)-4-triggered inflammatory response in PIE cells and; ii) to gain insight into the molecular
mechanisms involved in the anti-inflammatory effect of immunobiotics by evaluating the role of TLR2 and TLR negative
regulators in the modulation of proinflammatory cytokine production and activation of mitogen-activated protein kinase
(MAPK) and nuclear factor-kB (NF-kB) pathways in PIE cells.
Results: Bifidobacteria longum BB536 and B. breve M-16V strains significantly downregulated levels of interleukin (IL)-8,
monocyte chemotactic protein (MCP)-1 and IL-6 in PIE cells challenged with heat-killed enterotoxigenic Escherichia coli.
Moreover, BB536 and M-16V strains attenuated the proinflammatory response by modulating the NF-kB and MAPK
pathways. In addition, our findings provide evidence for a key role for the ubiquitin-editing enzyme A20 in the anti-
inflammatory effect of immunobiotic bifidobacteria in PIE cells.
Conclusions: We show new data regarding the mechanism involved in the anti-inflammatory effect of immunobiotics.
Several strains with immunoregulatory capabilities used a common mechanism to induce tolerance in PIE cells.
Immunoregulatory strains interacted with TLR2, upregulated the expression of A20 in PIE cells, and beneficially modulated
the subsequent TLR4 activation by reducing the activation of MAPK and NF-kB pathways and the production of
proinflammatory cytokines. We also show that the combination of TLR2 activation and A20 induction can be used as
biomarkers to screen and select potential immunoregulatory bifidobacteria strains.
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Introduction
The intestinal epithelium is a physical barrier that separates
trillions of commensal bacteria in the intestinal lumen from the
underlying lamina propria and deeper intestinal layers. Although
once considered simply a physical barrier, it is becoming
increasingly evident that the epithelium plays a crucial role as
a regulator of intestinal immune homeostasis. In response to
pathogens, intestinal epithelial cells (IECs) may produce a variety
of factors that play a crucial role in both the innate and adaptive
immune responses in the gut [1]. However, under steady-state
conditions, IECs should create a tolerogenic environment to avoid
inflammatory-mediated tissue damage. These two functions of
IECs – distinguishing among the diverse elements of the intestinal
microbiota and responding to pathogenic microorganisms – are
determined by pattern recognition receptors (PRRs) such as Toll-
like receptors (TLRs) [2,3].
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TLRs are the most extensively studied innate receptors, and
their roles in innate and adaptive mucosal immunity are well
documented. TLR signaling in IECs is involved in several
important mechanisms that are crucial for maintaining a healthy
epithelial barrier such as epithelial cell proliferation, maintenance
of tight junctions, expression of antimicrobial factors, and
modulation of immune responses [4]. However, inappropriate
TLR signaling contributes to loss of intestinal tolerance and results
in tissue injury. TLRs have been implicated in several immune-
mediated and inflammatory diseases. In fact, disruption of anti-
inflammatory and immunosuppressive mechanisms in the gut is
believed to lead to inflammatory diseases via hyperresponsiveness
to the commensal flora. TLR signaling plays an important role in
commensal-dependent colitis in several animal models [4,5].
In recent years, the study of microbe–IEC interactions has
unraveled several molecular mechanisms and cellular pathways,
showing that this interaction plays a crucial role in the regulation
of several immunological functions in the gut. Moreover, better
understanding of the host–microbe interactions in the gut has
provided new opportunities for preventing and treating a number
of inflammatory disorders such as the use of specific probiotic
strains to beneficially modulate the intestinal immune system.
Probiotic bacteria that can modulate the immune system
(immunobiotics) are demonstrably beneficial for treating a variety
of mucosal disorders, including inflammatory diseases [5,6]. In this
sense, we have developed and used several in vitro tests based in
porcine cells to identify anti-inflammatory, potentially immuno-
biotic strains and to study the mechanisms by which immunobio-
tics exert their immunoregulatory effects [7–9]. We have shown
that a mitogenic assay using porcine Peyer’s patches (PPs) and
mesenteric lymphoid node (MLN) immunocompetent cells and
evaluation of anti-inflammatory activities of lactic acid bacteria in
a porcine intestinal epithelial (PIE) cell line are useful for selecting
potential immunobiotic strains [7]. In addition, we have demon-
strated that PIE cells can be used to study the mechanisms
involved in the anti-inflammatory effect of immunobiotics in IECs
[2,10].
The aims of the present study were: i) to select potentially
immunomodulatory bacteria that may beneficially modulate the
TLR4-triggered inflammatory response in IECs and; ii) to gain
insight into the molecular mechanisms involved in the anti-
inflammatory effect of immunobiotics by evaluating the role of
TLR2 and TLR negative regulators in the regulation of
proinflammatory cytokine production and activation of mitogen-
activated protein kinase (MAPK) and nuclear factor kB (NF-kB)
pathways in PIE cells.
Results
Immunomodulatory Activity of Bacterial Strains in
Immune and PIE Cells
A commonly used method for studying the immunostimulatory
properties of potential probiotic microorganisms is evaluation of
the mitogenic activity [7]. We used this method to assess the
immunostimulatory capacity of 11 strains of different species of
lactobacilli, lactococci, and bifidobacteria using immunocompe-
tent cells isolated from swine PPs or MLNs (Figure 1A). All studied
strains significantly increased the mitogenic activity of PPs and
MLNs compared to the control group. The effect on PPs was
significantly higher for Bifidobacteria longum BB536, Lactobacillus
gasseri MCC-1183, and B. pseudolongum MCC-92 compared with
the other strains. In addition L. gasseri MCC-587 and L. helveticus
MCC-684 showed the lowest capacity to increase mitogenic
activity in MLN cells (Figure 1A).
We also evaluated the capacity of all the strains to modulate the
production of interleukin (IL)-6, IL-8, and monocyte chemotactic
protein (MCP)-1 in mononuclear cells from PPs (Figure 1B) and
MLNs (Figure 1C). IL-6 expression in PP mononuclear cells was
upregulated with the MCC-12, MCC-1375, and MCC-587
strains, whereas IL-8 mRNA levels were increased only with
MCC-1274 and MCC-1375 treatment. On the contrary, several
strains upregulated MCP-1 expression in PP cells, including
MCC-12, M-16V, MCC-1183, MCC-92, and MCC-866, which
showed the highest capacity (Figure 1B). Seven strains upregulated
IL-6 mRNA levels in MLN mononuclear cells, including MCC-
12, MCC-866, and MCC-684, which showed the strongest effect
(Figure 1C). In addition, BB536, MCC-12, MCC-1274, MCC-92,
and MCC-1723 upregulated the expression of IL-8 in MLN cells.
All strains increased MCP-1 expression in MLN cells with the
exception of BB536 and MCC-1183 (Figure 1C).
We studied the effect of the strains on cytokine production in
PIE cells and observed that several strains upregulated the
expression of IL-6 including BB536, M-16V, MCC-1375, MCC-
1183, and MCC-587 (Figure 1D). IL-8 mRNA levels were
increased in PIE cells stimulated with MCC-1274, MCC-92,
and MCC-587 strains, whereas MCC-1375 and MCC-1183 were
the only treatments that upregulated MCP-1 expression
(Figure 1D).
Identification of Bacterial Strains that Modulate the
Proinflammatory Response in PIE Cells
We next evaluated the potential anti-inflammatory effect of
bacterial strains in PIE cells with the aim of finding the strain with
the highest immunomodulatory capacity in this system. Because
TLR4 is expressed at a higher level than other TLRs in PIE cells
[8], we used heat-stable enterotoxigenic Escherichia coli (ETEC)
pathogen-associated molecular patterns (PAMPs) as the inflam-
matory challenge. The ETEC 987P strain used in this study does
not express agellin, and we have demonstrated that the main
molecule responsible for the inflammatory response triggered by
this bacterium is the lipopolysaccharide (LPS) present on its
surface [2,9]. PIE cells were cultured for 3 days and then
challenged with heat-stable ETEC PAMPs. In addition, individual
PIE cell cultures were stimulated with a single bacterial strain for
48 h and then challenged with ETEC PAMPs. Twelve hours after
stimulation, we determined mRNA levels of several cytokines
(Figure 2A). As we described previously [2], stimulation of PIE
cells with heat-stable ETEC PAMPs significantly increased the
mRNA levels of the proinflammatory cytokines MCP-1, IL-6, and
IL-8 (Figure 2A). Strains BB536, M-16V, MCC-1274, MCC-
1183, and MCC-1723 significantly downregulated expression of
IL-6 in response to heat-stable ETEC PAMPs challenge
(Figure 2A). Both L. gasseri MCC-1183 and MCC-587 strains
had the highest capacity to downregulate IL-8, whereas BB536,
M-16V, and MCC-1183 strongly downregulated MCP-1. We
selected B. longum BB536 and B. breve M-16V for further
experiments to test their immunoregulatory effects on PIE cells.
We also selected B. breve MCC-1274 (moderate anti-inflammatory
effect) and L. paracasei MCC-1375 (negative control).
To further confirm the immunoregulatory effect of B. longum
BB536 and B. breve M-16V and to detect protein to support the
transcriptional data for the selected cytokines, we conducted
enzyme-linked immunosorbent assays (ELISAs) to evaluate the
levels of IL-6, IL-8, and MCP-1 proteins (Figure 2B). PIE cells
were again stimulated with B. longum BB536, B. breve M-16V, B.
breve MCC-1274, or L. paracasei MCC-1375. Forty-eight hours
later, cells were challenged with heat-stable ETEC PAMPs,
which significantly increased levels of IL-6, IL-8, and MCP-1
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proteins in supernatants of bacteria-pretreated and control PIE
cells. However, pretreatment of PIE cells with B. longum BB536,
B. breve M-16V, or B. breve MCC-1274 significantly reduced the
protein levels of IL-6, IL-8, and MCP-1 (Figure 2B). Treatment
of PIE cells with L. paracasei MCC-1375 reduced the production
IL-6 in response to ETEC PAMPs challenge, but it did not
modify IL-8 and MCP-1 levels compared to ETEC control PIE
cells (Figure 2B).
Effect of Bacterial Strains on MAPK and NF-kB Pathways
in PIE Cells
We next evaluated whether B. longum BB536 and B. breveM-16V
attenuated the heat-stable ETEC PAMP-mediated proinflamma-
tory response by modulating the NF-kB pathway (Figure 3).
Challenge of PIE cells with heat-stable ETEC PAMPs significantly
reduced the levels of the counter-regulatory factor IkBa after 5 to
40 min, indicating activation of the NF-kB pathway. PIE cells
Figure 1. Selection of bacterial strains with immunomodulatory capacities. Bacteria were evaluated by studying (A) the mitogenic assay
and expression of cytokines in porcine Peyer_$B!G_(Bs patches (B), mesenteric lymphoid nodes (C), and porcine intestinal epithelial cells (D). Cells
were pre-treated with different bacterial strains for 48 h, and then the mitogenic activity or the expression of MCP-1, IL-6, and IL-8 were measured.
The results represent four independent experiments. Different letters indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0059259.g001
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previously stimulated with B. longum BB536 showed significantly
higher levels of IkBa after 10 min, and did not show significant
degradation of IkBa after 20 or 40 min, indicating an inhibitory
effect of the NF-kB pathway (Figure 3). In addition, no significant
modifications of IkBa were observed in B. breve M-16V-treated
PIE cells.
We also examined the relationship between MAPK activation
and the regulation of proinflammatory cytokines in PIE cells by
bifidobacteria (Figure 4). PIE cells were stimulated with B. longum
BB536, B. breve M-16V, or control medium, and the activation
profiles of p38, extracellular signal-regulated kinase (ERK), and
Jun N-terminal protein kinase (JNK) after ETEC challenge were
compared. Heat-stable ETEC PAMPs induced the phosphoryla-
tion of p38 and JNK after 5 min and the phosphorylation of ERK
between 10 and 40 min. B. longum BB536- and B. breve M-16V-
treated PIE cells showed significantly lower levels of phosphory-
lated p38 after 5 min than control cells (Figure 4). In addition, the
time course of JNK phosphorylation induced by heat-stable ETEC
PAMPs in PIE cells treated with bifidobacteria was different from
that in the control. Increased levels of phosphorylated JNK were
observed after 40 and 10 min for B. longum BB536- and B. breve M-
16V-treated PIE cells, respectively (Figure 4). We also observed the
phosphorylation of ERK between 20 and 40 min for B. longum
BB536-treated PIE cells, but no modification of ERK was
observed in B. breve M-16V-treated PIE cells (Figure 4).
Effect of Bacterial Strains on Negative Regulators of the
TLR Signaling Pathway in PIE Cells
We studied negative regulators that are known to mediate the
TLR signaling pathway. PIE cells were stimulated for 48 h with
bifidobacteria or L. paracasei MCC-1375, and the expression of
single immunoglobulin IL-1-related receptor (SIGIRR), Toll
interacting protein (Tollip), A20, B-cell lymphoma 3-encoded
protein (Bcl-3), mitogen-activated protein kinase 1 (MKP-1), and
interleukin-1 receptor-associated kinase M (IRAK-M) was de-
termined with real-time PCR 3, 6, and 12 h after ETEC PAMPs
challenge (Figure 5). No significant modifications in the expression
of TLR negative regulators after heat-stable ETEC PAMPs
challenge were observed compared to basal levels, with the
exception of the downregulation of Tollip and IRAK-M 6 h post-
challenge (Figure 5). We also observed that M-16V and MCC-
Figure 2. Expression of cytokines in porcine intestinal epithelial (PIE) cells after stimulation with heat-stable Enterotoxigenic
Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs). PIE cells were pre-treated with different bacterial strains for 48 h
and stimulated with heat-stable ETEC PAMPs. The expression of MCP-1, IL-6, and IL-8 mRNAs (A) and proteins levels (B) were studied at 12 h post-
stimulation. The results represent four independent experiments. Different letters indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0059259.g002
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1274 had the strongest effect on SIGIRR expression after ETEC
PAMPs challenge. These strains significantly increased SIGIRR
mRNA levels 3 and 6 h post-challenge (Figure 5). Tollip was
significantly upregulated in PIE cells treated with BB536 and M-
16V strains at all time points after ETEC PAMPs challenge
(Figure 5). In addition, expression of A20 was early and strongly
upregulated in PIE cells treated with B. longum BB536 and B. breve
M-16V. A20 mRNA levels were 4-fold higher in bifidobacteria-
treated PIE cells than in ETEC controls 3 h post-challenge. B.
breve MCC-1274 also upregulated A20, but its effect was
significantly lower than BB536 and M-16V strains (Figure 5). B.
longum BB536 was the only strain that significantly upregulated
Bcl-3 expression 3, 6, and 12 h post-challenge (Figure 5). In
addition, only the MCC-1274 strain upregulated MKP-1 expres-
sion 3 and 6 h after heat-stable ETEC PAMPs challenge (Figure 5).
M-16V and MCC-1375 increased IRAK-M 3 h after challenge,
but the effect of M-16V was significantly higher than that of
MCC-1375. Moreover, M-16V was the only strain that signifi-
cantly upregulated IRAK-M at all time points studied (Figure 5).
We also evaluated the effect of the TLR2 synthetic agonist
tripalmitoylated lipopeptide Pam3CysSerLys4 (Pam3CSK4) on
the expression of TLR negative regulators in PIE cells after heat-
stable ETEC PAMPs challenge. We observed increased levels of
A20, Tollip, IRAK-M, and SIGIRR mRNA levels 3 h post-
challenge in Pam3CSK4-treated PIE cells (Figure 5).
Role of TLR2 in the Anti-inflammatory Effect of Bacterial
Strains
Several studies have demonstrated that TLR2 is required for
some probiotics to exert their immunomodulatory effects [2,5,7].
Recently, we demonstrated that stimulation of PIE cells with
Lactobacillus jensenii TL2937 downregulates the levels of IL-6, IL-8,
and MCP-1 in response to heat-stable ETEC PAMPs or LPS
challenges and that TLR2 is partially involved in this immuno-
regulatory effect [2]. Thus, we next evaluated if TLR2 was also
involved in the anti-inflammatory effect of B. longum BB536 and B.
breve M-16V. We performed comparative studies with anti-TLR2
blocking antibodies (Figure 6) and observed that anti-TLR2
antibodies abolished the reduction in IL-6, IL-8, and MCP-1
induced by B. longum BB536 and B. breve M-16V. Considering the
early and strong upregulation of A20 that is induced by both B.
longum BB536 and B. breve M-16V in PIE cells and our previous
studies demonstrating that the induction of this TLR negative
regulator depends on TLR2 activation [2], we also performed
blocking experiments to evaluate the role of both TLR2 and A20
in the immunoregulatory effect of bifidobacteria. As shown in
Figure 6, the use of anti-TLR2 antibodies abolished the
upregulation of A20 induced by B. longum BB536 and B. breve
M-16V.
Discussion
Growing evidence suggests that some probiotics have immuno-
modulatory properties and that these properties are strain
dependent. In addition, studies comparing the immunoregulatory
effect of bifidobacteria and lactobacilli have shown in general that
bifidobacteria are better microorganisms for inducing tolerance
and exerting anti-inflammatory activities. Our current results are
consistent with these general considerations of probiotics. Of the
strains evaluated here, two bifidobacteria strains strongly regulated
the inflammatory response triggered by TLR4 activation in PIE
cells, whereas of the group of lactobacilli and lactococci, only L.
gasseri MCC-1183 achieved this effect. In addition, we observed
that B. breve M-16V and L. gasseri MCC-1183 showed higher
immunoregulatory activity in PIE cells compared with B. breve
MCC-1274 and L. gasseri MCC-587, respectively, confirming that
the immunoregulatory activity of probiotics is strain dependent.
Recent studies have shown that B. infantis 52486 and B. longum
SP07/3 strains increase the IL-10/IL-12 ratio in peripheral blood
mononuclear cells, whereas the known probiotic strains L. casei
Shirota and L. rhamnosus GG strains decrease this ratio [11].
Probiotic lactobacilli strains have thus been suggested to promote
T helper 1 cytokines, whereas bifidobacterial strains tend to
produce a more anti-inflammatory profile [12]. Lactobacillus
strains are generally considered to induce proinflammatory
cytokines, such as IL-12 and interferon-c, as well as anti-
inflammatory cytokines, such as IL-10, whereas Bifidobacterium
strains usually induce IL-10 better than lactobacilli [7,13,14]. In
the present study, we selected bifidobacteria strains to gain insight
into the mechanism involved in the immunoregulatory effect of
immunobiotics in PIE cells.
We demonstrated that B. longum BB536 and B. breve M-16V
significantly downregulated levels of IL-8, MCP-1, and IL-6 in
PIE cells challenged with heat-stable ETEC PAMPs. Moreover,
Figure 3. Western blot analysis of NF-kB pathway activation on porcine intestinal epithelial (PIE) cells after challenge with heat-
stable Enterotoxigenic Escherichia coli (ETEC) pathogen-associated molecular patterns (PAMPs). PIE cells were pre-treated with different
bacterial strains for 48 h and stimulated with heat-stable ETEC PAMPs. Levels of the counter-regulatory factor IkBa were studied at the indicated
times post-stimulation. Different letters indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0059259.g003
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we showed that both BB536 and M-16V strains attenuated the
proinflammatory response by modulating the NF-kB and MAPK
pathways (Figure 7). These modulatory properties of bifidobacteria
were also strain dependent. We observed that the BB536 strain
had a stronger effect than M-16V on the NF-kB pathway, whereas
this last strain was the only one that inhibited activation of the
ERK MAPK pathway in PIE cells.
The intestinal immune system must constantly maintain
a balance between activation and inhibition of TLRs to avoid
detrimental and inappropriate inflammatory responses [4,5].
Various negative regulatory mechanisms have evolved to attenuate
Figure 4. Western blot analysis of activation of p38 and JNK and ERK mitogen-activated protein kinases in porcine intestinal
epithelial (PIE) cells after challenge with heat-stable Enterotoxigenic Escherichia coli (ETEC) pathogen-associated molecular patterns
(PAMPs). PIE cells were pre-treated with different bacterial strains for 48 h and then stimulated with heat-stable ETEC PAMPs. Phosphorylation of
p38, JNK, and ERK was studied at the indicated times post-stimulation. Different letters indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0059259.g004
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TLR signaling to maintain this balance. In this sense, a growing
list of inhibitors of TLR signaling in IECs, including IRAK-M,
Tollip, SIGIRR, A20, and peroxisome proliferator-activated
receptor-c (PPARc), ensure that chronic inflammatory and
potentially destructive TLR responses to microbe-associated
molecular patterns (MAMPs) from commensal bacteria do not
occur [15]. In fact, commensal bacteria can modulate TLR
negative regulators in IECs. An anti-inflammatory mechanism has
been reported in which activation by commensal B. thetaiotaomicron
attenuates proinflammatory cytokine expression in IECs by
promoting nuclear export of the NF-kB subunit RelA, through
a PPARc-dependent pathway [16]. IECs deficient in SIGIRR are
more susceptible to commensal-dependent intestinal inflamma-
tion, indicating that the intrinsic expression of SIGIRR by IECs
regulates the communication between commensal bacteria and the
host immune system [17]. In addition, we have demonstrated that
TLR negative regulators play an important role in the anti-
inflammatory effect of some immunobiotics strains. We previously
showed that L. jensenii TL2937 attenuates the expression of
proinflammatory cytokines and chemokines caused by LPS
challenge in PIE cells by downregulating TLR4-dependent NF-
kB and MAPK activation via upregulation of A20, Bcl-3, and
MKP-1 [2]. We also reported that sustained upregulation of A20,
Tollip, and SIGIRR plays an important role in the anti-
inflammatory activity of L. casei MEP221114 in poly(I:C)-
challenged PIE cells [18]. Therefore, in this work, we evaluated
the effect of selected bifidobacteria strains on the expression of
several TLR negative regulators. Our findings provide evidence
for a key role for the ubiquitin-editing enzyme A20 in the anti-
inflammatory effect of immunobiotic bifidobacteria in porcine
IECs (Figure 7).
A20 is a zinc finger protein that inhibits activation of NF-kB via
inflammatory cytokine receptors [18,19], TLR [20,21], and the
nucleotide-binding oligomerization domain-containing receptor
NOD2 [22]. A20 functions via its two ubiquitin-editing activities,
an N-terminal deubiquitinase that removes K63-linked polyubi-
quitin chains and a C-terminal ubiquitin ligase that facilitates
target protein degradation via attachment of K48-linked poly-
ubiquitin chains [19,23]. These two activities cooperatively
downregulate the tumor necrosis factor (TNF)-a receptor-associ-
ated factor 6 [24]. Therefore, A20 plays an essential role in the
termination of NF-kB signaling in response to TNF-a and
microbial products such as LPS [25]. A20 deficiency in enterocytes
renders mice sensitive to TNF-a-induced lethal inflammation,
Figure 5. Expression of toll-like receptor negative regulators in porcine intestinal epithelial (PIE) cells. PIE cells were pre-treated with
different bacterial strains for 48 h, stimulated with heat-stable ETEC PAMPs, and the expression of IRAK-M, SIGIRR, Bcl-3, MKP-1, Tollip, and A20
negative regulators was studied at the indicated time points. The results represent four independent experiments. Different letters indicate
significant differences (P,0.05).
doi:10.1371/journal.pone.0059259.g005
Figure 6. Role of TLR2 in the immunomodulatory effect of Bifidobacterium longum BB536 and Bifidobacterium breveM-16V in porcine
intestinal epithelial (PIE) cells. PIE cells were pre-treated with BB536 or M-16V strains in the presence or absence of anti-TLR2 antibodies.
Untreated PIE cells were used as controls. PIE cells were stimulated with heat-stable Enterotoxigenic Escherichia coli (ETEC) pathogen-associated
molecular patterns (PAMPs), and then the expression of A20 mRNA levels and MCP-1, IL-6, and IL-8 protein levels were studied at 12 h post-
stimulation. The results represent four independent experiments. Different letters indicate significant differences (P,0.05).
doi:10.1371/journal.pone.0059259.g006
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leading to disruption of the epithelial barrier and infiltration of
commensal bacteria that initiate a systemic inflammatory response
[26]. These data suggest that A20 is important for the inhibition of
innate immune responses in the gut [15]. In addition, gut
decontamination with a mixture of antibiotics with limited oral
bioavailability in drinking water markedly reduces A20 protein
and mRNA levels in the ileal epithelium of mice [27]. Moreover,
partial rather than complete abrogation of A20 expression is likely
due to incomplete elimination of intestinal bacteria by the
antibiotic treatment [27]. These results show that A20 expression
in the epithelium positively correlates with the bacterial load in the
lumen. The observations that A20-deficient mice develop severe
gut inflammation early in life [28] and that this inflammatory state
can be alleviated by antibiotics or knockout of the TLR signaling
mediator myeloid differentiation factor MyD88 [29] further
support a key role for A20 in intestinal tolerance to the intestinal
microbiota.
In our work, the bifidobacteria with the highest capacity to
downregulate the expression of inflammatory cytokines in re-
sponse to heat-stable ETEC PAMPs upregulated A20 in PIE cells.
In fact, the most effective strains evaluated in our laboratory, L.
jensenii TL2937 [2] and bifidobacteria strains BB536 and M-16V,
strongly upregulated the ubiquitin-editing enzyme A20 (Figure 7).
This finding is of interest because it not only shows a common
mechanism for the anti-inflammatory activity of immunobiotics
but also provides a potential biomarker for the screening and
selection of new immunoregulatory strains.
Our results also show that other negative regulators of
inflammatory signaling are redundant with A20 in the activity of
immunobiotics. However, the combination of TLR negative
regulators that was upregulated in PIE cells was specific for each
strain (Figure 7), which would explain the different capacity of
BB536 and M-16V strains to modulate the NF-kB and MAPK
pathways. This differential effect could certainly be due to the
molecular complexity of the different bifidobacteria MAMPs that
may contact and activate the various PRRs expressed in PIE cells,
resulting in changes in PIE cells that are characteristic for each
strain.
We were also interested in evaluating the role of TLR2 in the
immunoregulatory effect of bifidobacteria. TLR2 plays an
important regulatory role in the recognition of immunoinhibitory
bifidobacteria. The supernatant of B. breve C50 induces dendritic
cell (DC) maturation and prolongs survival through TLR2, with
high IL-10 production [30]. Bifidobacteria inhibit the production
of IL-6 and TNF-a induced by immunostimulatory lactobacilli in
blood immune cells via interaction with TLR2 [31]. In addition,
bifidobacteria induce much higher levels of IL-12 and lower IL-10
levels in bone marrow-derived DCs from TLR22/2 mice
compared with wild-type DCs [31]. Our results also suggest that
TLR2 plays an important role in the anti-inflammatory activity of
bifidobacteria because the upregulation of A20 expression and the
reduction of proinflammatory mediators in heat-stable ETEC
PAMPs-challenged PIE cells were abolished when anti-TLR2
blocking antibodies were used. Moreover, the synthetic agonist for
TLR2, Pam3CSK4, significantly increased the levels of A20 in
PIE cells. TLR2 can induce tolerance to LPS that is referred to as
heterotolerance or cross-tolerance [32]. Therefore, bifidobacteria
may induce cross-tolerance in IECs through their interaction with
TLR2 and upregulation of A20. In fact, a common mechanism for
immunobiotics may be induction of tolerance in PIE cells because
we also demonstrated that L. jensenii TL2937 regulates the
inflammatory response in PIE cells via upregulation of A20 in
a TLR2-dependent manner [2].
Using Pam3CSK4, we also demonstrated here that TLR2
activation upregulated the expression of Tollip, Bcl-3, and IRAK-
M in PIE cells. We showed that the bifidobacteria strains with the
highest capacity to regulate the inflammatory response in PIE cells
also upregulated these TLR negative regulators (Figure 7).
Therefore, bifidobacteria strains with the capacity to activate
TLR2 have a higher ability to induce tolerance in the gut. This
idea is supported by our previous work demonstrating that
bifidobacteria strains with high capacity to activate TLR2-
overexpressing cells also efficiently stimulate IL-10-producing
CD4+ CD25high Foxp3+ Treg cells from swine PPs [7]. Moreover,
in this study, we also evaluated the expression of TLR negative
regulators in PIE cells treated with B. breve MCC-1274, which has
Figure 7. Proposed mechanism for the immunomodulatory effect of Bifidobacterium longum BB536 and Bifidobacterium breve M-16V
in porcine intestinal epithelial cells. The effect of bifidobacteria strains is compared with the previously studied immunobiotic strain,
Lactobacillus jensenii TL2937 [2].
doi:10.1371/journal.pone.0059259.g007
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a moderate anti-inflammatory effect compared with BB536 and
M-16V strains. We observed that upregulation of A20 in B. breve
MCC-1274-treated PIE cells was lower than in PIE cells pre-
stimulated with BB536 or M-16V strains. In addition, B. breve
MCC-1274 upregulated SIGIRR and MKP-1, TLR negative
regulators that seem to not be induced by TLR2 activation but by
other unknown receptor(s). These observations further support
a key role for TLR2 in the induction of tolerance by
immunobiotics in PIE cells.
Conclusions
The quest for a better understanding of how immunobiotics
work has boosted an enormous interest in the molecular processes
underlying host-microbe interactions. As recently reviewed [5,6],
the final conclusion of studies that have examined the molecular
mechanism of probiotic immunomodulatory activities is that their
effect depends on the combination of distinct MAMPs that interact
with various PRRs and the associated co-receptors that fine-tune
signaling, as well as on the quantity and quality of these MAMPs.
Therefore, host–immunobiotics interactions are not univocal but
involve the complex interactions of various microbial molecules
with various host receptors and adaptor molecules [33]. In this
paper, we provide new information regarding the mechanism
involved in the anti-inflammatory effect of immunobiotics by
demonstrating that several immunoregulatory strains use a com-
mon mechanism to induce tolerance in PIE cells. Immunoregu-
latory strains interact with TLR2, upregulate the expression of
A20 in PIE cells, and beneficially modulate the subsequent TLR4
activation by reducing the activation of MAPK and NF-kB
pathways and the production of proinflammatory cytokines.
Moreover, the results of this work demonstrated that the
combination of TLR2 activation and A20 induction can function
as biomarkers to screen and select potential immunoregulatory
bifidobacteria strains.
Materials and Methods
Microorganisms
Bifidobacteria, lactobacilli, and lactococci were provided by
Morinaga Milk Industry Co. Ltd (Zama, Japan). Eleven different
strains were used in the experiments: Bifidobacterium longum BB536;
Bifidobacterium breve M-16V and MCC-1274; Bifidobacterium infantis
MCC-12; Bifidobacterium pseudolongum MCC-92; Lactobacillus para-
casei MCC-1375; Lactobacillus gasseri MCC-1183 and MCC-587;
Lactococcus lactis MCC-866 and MCC-1723; and Lactobacillus
helveticus MCC-648. Bifidobacteria were grown in Man-Rogosa-
Sharpe (MRS) broth and agar (Difco, Detroit, MI) supplemented
with 0.05% (w/v) cysteine (Sigma, Tokyo, Japan) and incubated at
37uC for 16 h under anaerobic conditions (AnaeroGen; Oxoid,
Basingstoke, UK). Cultures were then centrifuged at 19006g for
10 min, and bifidobacteria were washed with phosphate-buffered
saline (PBS) and resuspended in Dulbecco’s modified Eagle’s
medium (DMEM) at the appropriate concentrations [7]. Lacto-
bacillus strains were grown in MRS medium for 16 h at 37uC,
washed with PBS, and resuspended in DMEM at the appropriate
concentrations. Lactococcus strains were grown in M17 broth
(Difco) supplemented with 0.5% (w/v) lactose (Wako, Osaka,
Japan) for 16 h at 37uC, washed with PBS, and resuspended in
DMEM at the appropriate concentrations.
ETEC strain 987P was kindly provided by Dr. M. Nakazawa,
National Institute of Animal Health (Tsukuba, Japan). ETEC
cells were plated into tryptic soy agar (Becton, Dickinson and
Company) supplemented with 5% sheep blood (Nippon Biotest
Laboratories Inc., Tokyo, Japan). After overnight incubation at
37uC, a single colony was transferred to tryptic soy broth and
grown for 24 h at 37uC with shaking (200 rpm). The
subcultures of bacteria that had grown to the mid-log phase
were centrifuged at 19006g for 10 min at 4uC, washed with
PBS, heat-treated at 65uC for 30 min, and resuspended in
DMEM as described [2]. We refer to this preparation as heat-
stable ETEC PAMPs.
PIE Cells
PIE cells, which are nontransformed intestinal cultured cells
originally derived from intestinal epithelia from an unsuckled
neonatal swine [8], were maintained in DMEM (Invitrogen
Corporation, Carlsbad, CA) supplemented with 10% fetal calf
serum (FCS), 100 mg/ml penicillin, and 100 U/ml streptomycin
at 37uC in an atmosphere of 5% CO2. PIE cells grow rapidly and
are well adapted to culture conditions even without transformation
or immortalization. However, the proliferative ability of PIE cells
diminishes after 50 passages in culture. Therefore, we used PIE
cells only between the 20th and 40th passages in these experiments.
Isolation of Immunocompetent Cells from Swine PPs and
MLNs
Suspensions of porcine PPs or MLN immunocompetent cells
were prepared from adult swine intestine as described [7,9]. This
study was carried out in strict accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of
the Guidelines for Animal Experimentation of Tohoku University,
Sendai, Japan. The present study was approved by the Institution
Animal Care and Use Committee of Tohoku University with
a permitted No. 2011-noudou-5 and all efforts were made to
minimize suffering [7]. Briefly, PPs or MLNs were cut into small
fragments, which were gently pressed through a nylon mesh and
washed three times in complete RPMI 1640 medium (Sigma, St.
Louis, MO) supplemented with 10% FCS (Sigma). Residual
erythrocytes were lysed by resuspending in hypotonic salt solution
(0.2% NaCl). Next, harvested PP or MLN cells were subjected to
hypertonic rescue in an equal volume of 1.5% NaCl. Finally,
immune cells were fractionated using Lympholyte-mammal
(Cedarlane, Hornby, Ontario, Canada) density gradient centrifu-
gation, and the isolated immune cells were suspended in complete
DMEM (Invitrogen, Tokyo, Japan) supplemented with 10% FCS
(Sigma) and 50 mg/ml penicillin-streptomycin (Life Tech., Carls-
bad, CA, USA).
Mitogenicity Assay
The mitogenicity assay was performed as described [7]. Briefly,
PPs or MLN immunocompetent cells were placed in a 96-well
microplate (Costar, 26105 cells/well) and incubated at 5% CO2,
37uC for 48 h in complete RPMI 1640 medium (Sigma)
supplemented with 2% FCS. Immune cells were stimulated with
bifidobacteria or lactobacilli for 48 h. During the final hour of
culture, the cells were radiolabeled with 9.25 kBq per well of
[methyl-3H]-Thymidine (GE Healthcare, Tokyo, Japan). The cells
were then harvested with a glass fibre filter (PerkinElmer Japan,
Kanagawa, Japan). The [methyl-3H]-Thymidine incorporation
was quantitated in a liquid scintillation counter (Beckman
Instruments, Palo Alto, CA, USA). Results are presented as the
SI, calculated with the following equation: [(counts per minute in
treated cultures) 2 (counts per minute in background)]/[(counts
per minute in control cultures) 2 (counts per minute in
background)].
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Immunomodulatory Effect of Bacteria
Evaluation of the immunomodulatory activity of lactobacilli and
bifidobacteria strains was performed using mononuclear cells from
PPs and MLNs or PIE cells. In each case, cells were plated at
a density of 1.56106 cells/well in 12-well type I collagen-coated
plates (Iwaki, Tokyo, Japan). Bacteria were added to each well at
a concentration of 56108 cells/ml. Cells were incubated with
bacteria for 48 h. Expression of IL-6, IL-8, and MCP-1 was
evaluated with RT-PCR as described below. In addition,
expression levels of six TLR negative regulators, A20, Bcl-3,
IRAK-M, MKP-1, SIGIRR, and Tollip, were evaluated in PIE
cells. In some experiments, unlabeled anti-porcine TLR2-rabbit
IgG (Santa Cruz Biotechnology, Santa Cruz, CA) was used in
blocking experiments. Cultured porcine cells were incubated with
unlabeled anti-TLR2 antibodies for 12 h before stimulation with
bacteria.
Anti-inflammatory Assay in PIE Cells
PIE cells were seeded at 36104 cells/12-well plate on type I
collagen-coated plates (Iwaki) and cultured for 3 days. After
changing medium, bacteria (56107 cells/ml) were added; 48 h
later, each well was washed vigorously with medium at least three
times to eliminate all stimulants, and then cells were stimulated
with heat-stable ETEC PAMPs (equivalent to 56107 cells/ml) for
12 h.
Quantitative Analysis of Expression with Real-time PCR
We performed two-step real-time quantitative PCR to charac-
terize the expression of mRNAs in PIE cells and immune cells.
Total RNA was isolated from each PIE or immune cell sample
using TRIzol reagent (Invitrogen). All cDNAs were synthesized
using a Quantitect reverse transcription (RT) kit (Qiagen, Tokyo,
Japan) according to the manufacturer’s recommendations. Real-
time quantitative PCR was carried out using a 7300 real-time
PCR system (Applied Biosystems, Warrington, UK) and the
Platinum SYBR green qPCR SuperMix uracil-DNA glycosylase
with 6-carboxyl-X-rhodamine (Invitrogen). The primers for IL-6,
IL-8, MCP-1, A20, SIGIRR, Tollip, Bcl-3, MKP-1, and IRAK-M
used in this study were previously described [2,9]. The PCR
cycling conditions were 5 min at 50uC, followed by 5 min at 95uC,
and then 40 cycles of 15 s at 95uC, 30 s at 60uC, and 30 s at 72uC.
The reaction mixtures contained 2.5 ml sample cDNA and 7.5 ml
master mix, which included the sense and antisense primers.
Expression of b-actin in each sample was assessed, and the b-actin
data were used as an internal control to normalize differences
between samples and to calculate relative expression levels.
ELISA
The concentrations of IL-6, IL-8, and MCP-1 secreted into the
supernatant of PIE cell cultures 48 h after ETEC stimulation were
determined using commercially available ELISA kits (porcine IL-6
ELISA kit [Ray-Bio, Norcross, GA], IL-8 immunoassay kit
[Biosource, Camarillo, CA], and porcine MCP-1 ELISA kit
[E101–800, Bethyl Laboratories, Inc. Montgomery, TX, USA]),
according to the manufacturers’ instructions.
Western Blotting
PIE cells (1.86105 cells/dish) cultured in 60-mm dishes were
stimulated with bacteria as described previously. PIE cells were
then washed and stimulated with ETEC for the indicated times,
washed three times with PBS, and resuspended in 200 ml CelLytic
M cell lysis reagent (Sigma) including protease and phosphate
inhibitors (Complete Mini, PhosSTOP; Roche, Mannheim,
Germany). Cells were transferred into Eppendorf tubes and boiled
for 5 min at 95uC. Protein concentration was measured using the
bicinchoninic acid protein assay kit (Pierce, Rockford, IL). Total
protein samples (2 mg/sample) were loaded onto 10% SDS-
polyacrylamide gels. Separated proteins were electrophoretically
transferred to a nitrocellulose membrane. Phosphorylation of p38
and JNK and ERK MAPKs, and IkBa degradation were
evaluated using anti-phosphorylated p38, anti-phosphorylated
JNK, anti-phosphorylated ERK, and anti-IkB antibodies, re-
spectively (Cell Signaling Technology, Beverly, MA), according to
the manufacturer’s instructions. The optical density of each band
was measured using Image J (National Institutes of Health,
Bethesda, MD).
Statistical Analysis
Statistical analyses were performed using the GLM and REG
procedures available in the SAS computer program (SAS, 1994).
Comparisons between mean values were carried out using one-
way analysis of variance and Fisher’s least-significant-difference
test. For these analyses, P values of ,0.05 were considered
significant.
Author Contributions
Conceived and designed the experiments: YT JV HA J-zX T. Saito HK.
Performed the experiments: YT JV KM EC T. Shimazu NI. Analyzed the
data: YT JV KM HK. Contributed reagents/materials/analysis tools: HK.
Wrote the paper: YT JV HK.
References
1. Wells JM, Rossi O, Meijerink M, van Baarlen P (2011) Epithelial crosstalk at the
microbiota-mucosal interface. Proc Natl Acad Sci USA 108: 460724614.
2. Shimazu T, Villena J, Tohno M, Fujie H, Hosoya S, et al. (2012) Immunobiotic
Lactobacillus jensenii elicit anti-inflammatory activity in porcine intestinal epithelial
cells by modulating negative regulators of the toll-like receptor signaling
pathway. Infect Immun 80: 2762288.
3. Westendorf AM, Fleissner D, Hansen W, Buer J (2010) T cells, dendritic cells
and epithelial cells in intestinal homeostasis. Int J Med Microbiol 300: 11218.
4. Cerf-Bensussan N, Gaboriau-Routhiau V (2010) The immune system and the
gut microbiota: friends or foes? Nat Rev Immunol 10: 7352744.
5. Villena J, Aso H, Alvarez S, Kitazawa H (2012) Porcine toll-like receptors and
their crosstalk with immunobiotics: impact in the regulation of gut inflammatory
immunity. In: Probiotics: Sources, Types and Health Benefits. NOVA Science
publishers, In press.
6. Bron PA, van Baarlen P, Kleerebezem M (2011) Emerging molecular insights
into the interaction between probiotics and the host intestinal mucosa. Nat Rev
Microbiol 10: 66278.
7. Fujie H, Villena J, Tohno M, Morie K, Simazu T, et al. (2011) Toll-like
receptor-2 activating bifidobacteria strains differentially regulate inflammatory
cytokines in porcine intestinal epithelial cell culture system: finding new anti-
inflammatory immunobiotics. FEMS Immunol Med Microbiol 63: 1292139.
8. Moue M, Tohno M, Shimazu T, Kido T, Aso H, et al. (2008) Toll-like receptor
4 and cytokine expression involved in functional immune response in an
originally established porcine intestinal epitheliocyte cell line. Biochim Biophys
Acta 1780: 1342144.
9. Villena J, Suzuki R, Fujie H, Chiba E, Takahashi T, et al. (2012) Immunobiotic
Lactobacillus jensenii modulates the Toll-like receptor 4-induced inflammatory
response via negative regulation in porcine antigen-presenting cells. Clin
Vaccine Immunol 19: 103821053.
10. Hosoya S, Villena J, Simazu T, Tohno M, Fujie H, et al. (2011) Immunobiotic
lactic acid bacteria beneficially regulate immune response triggered by poly(I:C)
in porcine intestinal epithelial cells. Vet Res 42: 111.
11. You J, Yaqoob P (2012) Evidence of immunomodulatory effects of a novel
probiotic, Bifidobacterium longum bv. infantis CCUG 52486. FEMS Immunol Med
Microbiol In press.
12. Dong H, Rowland I, Yaqoob P (2012) Comparative effects of six probiotic
strains on immune function in vitro. Br J Nutr 108: 4592470.
Bifidobacteria Modulate A20 in PIE Cells
PLOS ONE | www.plosone.org 11 March 2013 | Volume 8 | Issue 3 | e59259
13. Lopez P, Gueimonde M, Margolles A, Suarez A (2010) Distinct Bifidobacterium
strains drive different immune responses in vitro. Int J Food Microbiol 138: 157–
165.
14. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, et al. (2004) Modulation of
human dendritic cell phenotype and function by probiotic bacteria. Gut 53:
160221609.
15. Shibolet O, Podolsky DK (2007) TLRs in the Gut. IV. Negative regulation of
Toll-like receptors and intestinal homeostasis: Addition by subtraction.
Am J Physiol Gastrointest Liver Physiol 292: G14692G1473.
16. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, et al. (2004) Commensal
anaerobic gut bacteria attenuate inflammation by regulating nuclear- cytoplas-
mic shuttling of PPAR-gamma and RelA. Nat Immunol 5: 1042112.
17. Xiao H, Gulen MF, Qin J, Yao J, Bulek K, et al. (2007) The Toll-interleukin-1
receptor member SIGIRR regulates colonic epithelial homeostasis, inflamma-
tion, and tumorigenesis. Immunity 26: 4612475.
18. Hosoya S, Villena J, Chiba E, Shimazu T, Suda Y, et al. (2012) Advanced
application of porcine intestinal epithelial cells for the selection of immunobiotics
modulating toll-like receptor 3-mediated inflammation. J Microbiol Immunol
Infect In press.
19. Song HY, Rothe M, Goeddel DV (1996) The tumor necrosis factor-inducible
zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kB
activation. Proc Natl Acad Sci USA 93: 672126725.
20. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, et al. (2004) The
ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor
responses. Nat Immunol 5: 105221060.
21. Wang YY, Li L, Han KJ, Zhai Z, Shu HB (2004) A20 is a potent inhibitor of
TLR3- and Sendai virus-induced activation of NF-kB and ISRE and IFN-beta
promoter. FEBS Lett 576: 86290.
22. Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, et al. (2008) The
ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization
domain containing 2-triggered signals. Immunity 28: 3812390.
23. Lin SC, Chung JY, Lamothe B, Rajashankar K, Lu M, et al. (2008) Molecular
basis for the unique deubiquitinating activity of the NF-kB inhibitor A20. J Mol
Biol 376: 5262540.
24. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, et al. (2007) Site-
specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-
ubiquitination is a critical determinant of IkB kinase activation. J Biol Chem 282:
410224112.
25. Werner SL, Kearns JD, Zadorozhnaya V, Lynch C, O’Dea E, et al. (2008)
Encoding NF-kB temporal control in response to TNF: distinct roles for the
negative regulators IkBa and A20. Genes Dev 22: 209322101.
26. Vereecke L, Sze M, McGuire C, Rogiers B, Chu Y, et al. (2010) Enterocyte-
specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and
experimental colitis. J Exp Med 207: 151321523.
27. Wang J, Ouyang Y, Guner Y, Ford HR, Grishin AV (2009) Ubiquitin-editing
enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J Immunol
183: 138421392.
28. Lee EG, Boone DL, Chai S, Libby SL, Chien M, et al. (2000) Failure to regulate
TNF-induced NF-kB and cell death responses in A20-deficient mice. Science
289: 235022354.
29. Turer EE, Tavares RM, Mortier E, Hitotsumatsu O, Advincula R, et al. (2008)
Homeostatic MyD88-dependent signals cause lethal inflammation in the
absence of A20. J Exp Med 205: 4512464.
30. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y (2006)
Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation,
and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol
117: 6962702.
31. Zeuthen LH, Fink LN, Frøkiaer H (2008) Toll-like receptor 2 and nucleotide-
binding oligomerization domain-2 play divergent roles in the recognition of gut-
derived lactobacilli and bifidobacteria in dendritic cells. Immunol 124:
4892502.
32. Otte JM, Podolsky DK (2004) Functional modulation of enterocytes by gram-
positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver
Physiol. 286: G6132G626.
33. Lebeer S, Vanderleyden J, De Keersmaecker SC (2010) Host interactions of
probiotic bacterial surface molecules: comparison with commensals and
pathogens. Nat Rev Microbiol 8: 1712184.
Bifidobacteria Modulate A20 in PIE Cells
PLOS ONE | www.plosone.org 12 March 2013 | Volume 8 | Issue 3 | e59259
